Ondine Biomedical (OTC : OBIMF) Stock

Ondine Biomedical Inc. is a Canada-based biotechnology company. The Company is engaged in the development and commercialization of anti-infective therapies covering a various bacterial, fungal and viral infections primarily using antimicrobial photodynamic therapy (aPDT) as a platform technology for its products, which are used as an alternative to the use of antibiotics. The Company¿s aPDT products uses laser-based activation of compounds to treat a range of medical infections. Its Photodisinfection platform, is a light-based antimicrobial technology that provides rapid destruction of a range of pathogens without causing antibiotic resistance. The Company offers Steriwave product, which is a photodisinfection-based medical device to eliminate harmful nasal pathogens that can lead to healthcare-associated infections (HAIs).